Bruce G. Pollock, MD, PhD
- 25Articles
- 73.4KReads
- 1997–2021Active
- 91Collaborators
- 302Citations
About
Bruce G. Pollock, MD, PhD, is affiliated with the Campbell Family Mental Health Research Institute at CAMH and the University of Toronto in Ontario, Canada. Since 1997, Pollock has published extensively on topics including major depressive disorder, schizophrenia and schizoaffective disorders, cognition, Alzheimer's disease, addiction, anxiety, and dementia. His research has addressed clinical areas such as anticholinergic burden and cognition in schizophrenia, symptom domains predicting functioning in psychotic disorders, and treatment approaches for late-life depression and agitation in dementia. Frequent collaborators include Benoit H. Mulsant, Charles F. Reynolds III, and Philip Gerretsen.
Publications
Increasing Versus Maintaining the Dose of Olanzapine or Risperidone in Schizophrenia Patients Who Did Not Respond to a Modest Dosage: A Double-Blind Randomized Controlled Trial
October 26, 2016
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
